Visiomed Group SA

ALVMG.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALVMG.PA stands at 53M. In comparison, EL.PA has a market cap of 118.1B. Regarding current trading prices, ALVMG.PA is priced at €0.17, while EL.PA trades at €252.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALVMG.PA currently has a P/E ratio of -17.26, whereas EL.PA's P/E ratio is 49.65. In terms of profitability, ALVMG.PA's ROE is +0.04%, compared to EL.PA's ROE of +0.06%. Regarding short-term risk, ALVMG.PA is more volatile compared to EL.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALVMG.PA.Check EL.PA's competition here

ALVMG.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALVMG.PA stands at 53M. In comparison, DIM.PA has a market cap of 16.5B. Regarding current trading prices, ALVMG.PA is priced at €0.17, while DIM.PA trades at €169.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALVMG.PA currently has a P/E ratio of -17.26, whereas DIM.PA's P/E ratio is 73.28. In terms of profitability, ALVMG.PA's ROE is +0.04%, compared to DIM.PA's ROE of +0.05%. Regarding short-term risk, ALVMG.PA is more volatile compared to DIM.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALVMG.PA.Check DIM.PA's competition here

ALVMG.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALVMG.PA stands at 53M. In comparison, AMPLI.PA has a market cap of 299.8M. Regarding current trading prices, ALVMG.PA is priced at €0.17, while AMPLI.PA trades at €6.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALVMG.PA currently has a P/E ratio of -17.26, whereas AMPLI.PA's P/E ratio is 312.50. In terms of profitability, ALVMG.PA's ROE is +0.04%, compared to AMPLI.PA's ROE of +0.01%. Regarding short-term risk, ALVMG.PA is more volatile compared to AMPLI.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALVMG.PA.Check AMPLI.PA's competition here

ALVMG.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALVMG.PA stands at 53M. In comparison, ALCJ.PA has a market cap of 80.6M. Regarding current trading prices, ALVMG.PA is priced at €0.17, while ALCJ.PA trades at €1.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALVMG.PA currently has a P/E ratio of -17.26, whereas ALCJ.PA's P/E ratio is -5.69. In terms of profitability, ALVMG.PA's ROE is +0.04%, compared to ALCJ.PA's ROE of +3.77%. Regarding short-term risk, ALVMG.PA is less volatile compared to ALCJ.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ALVMG.PA.Check ALCJ.PA's competition here

ALVMG.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALVMG.PA stands at 53M. In comparison, MLBON.PA has a market cap of 7.6M. Regarding current trading prices, ALVMG.PA is priced at €0.17, while MLBON.PA trades at €12.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALVMG.PA currently has a P/E ratio of -17.26, whereas MLBON.PA's P/E ratio is -7.25. In terms of profitability, ALVMG.PA's ROE is +0.04%, compared to MLBON.PA's ROE of -0.01%. Regarding short-term risk, ALVMG.PA is less volatile compared to MLBON.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ALVMG.PA.Check MLBON.PA's competition here

ALVMG.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALVMG.PA stands at 53M. In comparison, ALPIX.PA has a market cap of 1.2M. Regarding current trading prices, ALVMG.PA is priced at €0.17, while ALPIX.PA trades at €0.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALVMG.PA currently has a P/E ratio of -17.26, whereas ALPIX.PA's P/E ratio is -0.05. In terms of profitability, ALVMG.PA's ROE is +0.04%, compared to ALPIX.PA's ROE of -6.46%. Regarding short-term risk, ALVMG.PA is less volatile compared to ALPIX.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ALVMG.PA.Check ALPIX.PA's competition here

ALVMG.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALVMG.PA stands at 53M. In comparison, ALSAF.PA has a market cap of 218.9K. Regarding current trading prices, ALVMG.PA is priced at €0.17, while ALSAF.PA trades at €24.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALVMG.PA currently has a P/E ratio of -17.26, whereas ALSAF.PA's P/E ratio is -0.00. In terms of profitability, ALVMG.PA's ROE is +0.04%, compared to ALSAF.PA's ROE of +2.02%. Regarding short-term risk, ALVMG.PA is less volatile compared to ALSAF.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ALVMG.PA.Check ALSAF.PA's competition here

ALVMG.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALVMG.PA stands at 53M. In comparison, ALICR.PA has a market cap of 155.7K. Regarding current trading prices, ALVMG.PA is priced at €0.17, while ALICR.PA trades at €0.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALVMG.PA currently has a P/E ratio of -17.26, whereas ALICR.PA's P/E ratio is -0.10. In terms of profitability, ALVMG.PA's ROE is +0.04%, compared to ALICR.PA's ROE of -2.62%. Regarding short-term risk, ALVMG.PA is less volatile compared to ALICR.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ALVMG.PA.Check ALICR.PA's competition here

ALVMG.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALVMG.PA stands at 53M. In comparison, ALSPW.PA has a market cap of 106.6K. Regarding current trading prices, ALVMG.PA is priced at €0.17, while ALSPW.PA trades at €0.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALVMG.PA currently has a P/E ratio of -17.26, whereas ALSPW.PA's P/E ratio is -0.16. In terms of profitability, ALVMG.PA's ROE is +0.04%, compared to ALSPW.PA's ROE of -0.19%. Regarding short-term risk, ALVMG.PA is more volatile compared to ALSPW.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALVMG.PA.Check ALSPW.PA's competition here